Literature DB >> 7059467

Postchemotherapy staging laparotomy in Hodgkin's disease.

L C Barr, J P Glees, T J McElwain, M J Peckham, J C Gazet.   

Abstract

Seventeen patients with Hodgkin's disease who had a staging laparotomy (SL) within 2 months of the completion of initial chemotherapy are presented. Only 1 patient had a positive laparotomy. Postchemotherapy SL allows any residual active disease to be assessed, but the incidence of positive finding may be small, and such findings are unlikely to alter subsequent management. SL following chemotherapy is therefore not recommended either for patients in clinical remission or for patients with evidence of relapsed disease.

Entities:  

Mesh:

Year:  1982        PMID: 7059467      PMCID: PMC2010884          DOI: 10.1038/bjc.1982.30

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  5 in total

1.  Long-term results of the E.O.R.T.C. randomized study of irradiation and vinblastine in clinical stages I and II of Hodgkin's disease.

Authors:  M Tubiana; M Henry-Amar; M Hayat; K Breur; B van der Werf-Messing; M Burgers
Journal:  Eur J Cancer       Date:  1979-05       Impact factor: 9.162

2.  Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission.

Authors:  E Frei; J K Luce; J F Gamble; C A Coltman; J J Constanzi; R W Talley; R W Monto; H E Wilson; J S Hewlett; F C Delaney; E A Gehan
Journal:  Ann Intern Med       Date:  1973-09       Impact factor: 25.391

3.  Post-treatment laparotomy in the management of Hodgkin's disease.

Authors:  S B Sutcliffe; D Katz; A G Stansfeld; W S Shand; P F Wrigley; J S Malpas
Journal:  Lancet       Date:  1978-07-08       Impact factor: 79.321

4.  Adriamycin, bleomycin, vinblastine and imidazole carboxamide (ABVD) therapy for advanced Hodgkin's disease resistant to mustine, vinblastine, procarbazine and prednisolone (MVPP).

Authors:  S B Sutcliffe; P F Wrigley; A G Stansfeld; J S Malpas
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

5.  Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's disease.

Authors:  S B Kaye; C A Juttner; I E Smith; A Barrett; D E Austin; M J Peckham; T J McElwain
Journal:  Br J Cancer       Date:  1979-02       Impact factor: 7.640

  5 in total
  1 in total

1.  Postchemotherapy staging laparotomy in Hodgkin's disease.

Authors:  R Kuse; A Calavrezos; K Hausmann
Journal:  Br J Cancer       Date:  1982-12       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.